Frances has 9 years of experience in strategic project and change management, product launch, and innovation in the life science industry. After being on the supplier side of the pharmaceutical industry, Frances began working with TransCelerate BioPharma Inc. in 2019. Having managed workstreams focused on common fields for Serious Adverse Event (SAE) reporting, patient-level data privacy, and ambiguous clinical trial regulations, she now supports Transcelerate’s Interpretation of Pharmacovigilance Guidances & Regulations work.